会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明申请
    • Fluid Composition Having Excellent Fire-Resistance
    • 具有优异耐火性的流体组合物
    • US20080132436A1
    • 2008-06-05
    • US11566841
    • 2006-12-05
    • John Sherman
    • John Sherman
    • C10M129/00
    • C10M111/04C10M2207/282C10M2207/283C10M2207/285C10M2209/1045C10M2209/1055C10M2209/1065C10M2209/1075C10M2219/108C10N2230/08C10M2207/281C10M2209/1085
    • A fluid composition includes a poly(alkylene glycol) present in an amount of greater than 85 parts by weight based on the total weight of the fluid composition, and a sterically hindered ester present in an amount of from 0.5 up to 15 parts by weight based on the total weight of the fluid composition. The sterically hindered ester, present in the amount of from 0.5 up to 15 parts by weight based on the total weight of the fluid composition, provides the fluid compositions with excellent fire resistance, without adversely affecting other physical properties of the fluid compositions such as hydrolytic stability. More specifically, the sterically hindered ester has a higher fire point (Fp) than the poly(alkylene glycol), which typically sufficiently lowers the S.F.P. of the fluid composition to allow the fluid composition to rate as a Factory Mutual Approved Fluid.
    • 流体组合物包含以流体组合物的总重量计大于85重量份的量存在的聚(亚烷基二醇)和以0.5至15重量份以上的量存在的空间位阻酯 关于流体组合物的总重量。 基于流体组合物的总重量,空间位阻酯以0.5至15重量份的量存在,为流体组合物提供优异的耐火性,而不会不利地影响流体组合物的其它物理性能,例如水解 稳定性。 更具体地说,空间位阻的酯具有比聚(亚烷基二醇)更高的火点(F> P),其通常足以降低S.F.P. 的流体组合物,以允许流体组合物作为工厂相互认可的流体进行评估。
    • 14. 发明申请
    • TREATING SLEEP DEPRIVATION USING ANESTHETIC AGENT
    • 使用麻醉剂治疗睡眠休息
    • US20060149216A1
    • 2006-07-06
    • US11164811
    • 2005-12-06
    • John Sherman
    • John Sherman
    • A61M31/00A62B17/04
    • A61K31/00A61K33/00A61M31/00A61K2300/00
    • A method for treating a person having sleep deprivation includes actively inducing unconsciousness in a person by administering an anesthetic agent to the person; determining an indication of a stage of sleep of the unconscious person by monitoring brainwaves of the person; and maintaining, for a predetermined period of time, the person in a state of sleep indicated to be deep sleep by adjusting the amount of the anesthetic agent being administered to the person. Preferably, the anesthetic agent is administered for about seven hours at different rates, and no surgical or other medical operation is performed. The anesthetic agent preferably is administered for the sole purpose of treating sleep deprivation.
    • 治疗睡眠剥夺者的方法包括通过向人施用麻醉剂来积极地诱导人的无意识; 通过监测人的脑电波来确定无意识人员的睡眠阶段的指示; 并且通过调整向人施用的麻醉剂的量,在预定时间段内维持处于睡眠状态的人被指示为深度睡眠。 优选地,麻醉剂以不同的速率施用约7小时,并且不进行手术或其它医疗操作。 麻醉剂优选仅用于治疗睡眠剥夺的目的。